HealthcareServices

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theSodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

The rising prevalence of diabetes is expected to drive the growth of the sodium glucose cotransporter 2 (SGLT2) inhibitor market. Diabetes is increasing due to factors such as urbanization, stress, and poor healthcare access. SGLT2 inhibitors are used to lower blood glucose levels by preventing glucose reabsorption in the kidneys. They also offer cardiovascular and renal benefits, making them an effective treatment for diabetes. According to the Australian Bureau of Statistics in December 2023, 5.3% of Australians were diagnosed with diabetes in 2022. This increasing prevalence is driving the growth of the SGLT2 inhibitor market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18473&type=smp

#What is the Anticipated CAGR of theSodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, and What Factors Will Drive It?

The sodium glucose cotransporter 2 (SGLT2) inhibitors market has seen notable growth in recent years. It will rise from $10.17 billion in 2024 to $11.07 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.8%. The growth is driven by successful clinical trials, rising regulatory approvals, increasing diabetes diagnoses, and demand for innovative diabetes treatments.

The sodium glucose cotransporter 2 (SGLT2) inhibitors market size is expected to reach $15.4 billion by 2029, with a CAGR of 8.6%. Growth factors include rising diabetes prevalence, increasing obesity rates, awareness of diabetes management, and expanding applications in heart and kidney disease treatments. Key trends include combination therapies, personalized medicine, technological advancements, and traditional drug development.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18473

Which Cutting-Edge Market Trends Are Expected to Drive theSodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market’s Growth?

Companies in the sodium glucose cotransporter 2 (SGLT2) inhibitor market are working on dual inhibitor therapies to improve blood sugar management. Lexicon Pharmaceuticals introduced sotagliflozin in May 2023, a dual SGLT1 and SGLT2 inhibitor for heart failure treatment, offering benefits like reduced cardiovascular risk and improved renal function.

What Are the Leading Market Players Impacting theSodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market’s Growth Trend?

Major companies operating in the sodium glucose cotransporter 2 (SGLT2) inhibitors market are Pfizer Inc., Johnson & Johnson Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmBH, Astellas Pharma Inc, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Sumitomo Dainippon Pharma Co. Ltd., Taisho Pharmaceutical Holdings Co. Ltd., Lupin Limited, Glenmark pharmaceuticals, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Kissei Pharmaceutical Co. Ltd., Patsnap Synapse, Kotobuki Pharmaceutical Co Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/sodium-glucose-cotransporter-2-sglt2-inhibitors-global-market-report

How Are the Key Segments of the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Driving Opportunities and Innovations?

The sodium glucose cotransporter 2 (SGLT2) inhibitors market covered in this report is segmented –

1) By Type: Invokana, Jardiance, Farxiga Or Forxiga, Suglat

2) By Route Of Administration: Oral Route, Other Route Of Administration

3) By End User: Hospitals, Homecare Settings, Clinics

Subsegments:

1) By Invokana: Generic Invokana (Canagliflozin), Branded Invokana

2) By Jardiance: Generic Jardiance (Empagliflozin), Branded Jardiance

3) By Farxiga Or Forxiga: Generic Farxiga (Dapagliflozin), Branded Farxiga

4) By Suglat: Suglat (Sotagliflozin) For Diabetes, Suglat (Sotagliflozin) For Heart Failure

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=18473&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theSodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?# Market Expansion?

North America was the largest region in the sodium glucose cotransporter 2 (SGLT2) inhibitors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sodium glucose cotransporter 2 (SGLT2) inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market 2025, By The Business Research Company:

Sodium Benzoate Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/sodium-benzoate-global-market-report

Sodium Lauryl Ether Sulfate [SLES] Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/sodium-lauryl-ether-sulfate-sles-global-market-report

Sodium Cocoyl Isethionate Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/sodium-cocoyl-isethionate-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: